For the quarter ending 2026-03-31, GNLX had $3,940K increase in cash & cash equivalents over the period. -$6,980K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -8,928 | -9,247 | -7,950 | -14,948 |
| Depreciation expense | 9 | 60 | 62 | 122 |
| Net amortization of premiums and discounts on marketable securities | -118 | - | 31 | 157 |
| Accretion of discount on marketable securities | - | 226 | - | - |
| Right-of-use asset | 89 | 88 | 82 | 160 |
| Stock compensation | 1,394 | 1,535 | 1,623 | 2,713 |
| Fair value of restricted stock units | 319 | 320 | 290 | 288 |
| Cost of stock option modifications and repricing | -68 | -68 | -725 | -13 |
| Prepaid expenses and other assets | 10 | -79 | -577 | 590 |
| Accounts payable and accrued expenses | 1,737 | 374 | -2,040 | 453 |
| Accrued payroll and payroll taxes | -580 | 655 | 170 | -387 |
| Lease liability | -87 | -93 | -83 | -161 |
| Net cash used in operating activities | -6,059 | -6,199 | -6,575 | -12,494 |
| Purchases of property and equipment | 921 | 436 | 517 | 145 |
| Purchase of marketable securities | 14,398 | 0 | 5,262 | 12,999 |
| Proceeds from maturities of marketable securities | 6,780 | 7,000 | 10,500 | 14,000 |
| Net cash (used in) provided by investing activities | -8,539 | 6,564 | 4,721 | 856 |
| Proceeds from common stock issued in connection with the companys equity award programs | - | 52 | 0 | 52 |
| Proceeds from the exercise of stock options | 13 | 0 | - | 14 |
| Proceeds from the exercise of stock warrants | - | 210 | 14 | 0 |
| Proceeds from common stock issued | 18,525 | 0 | 0 | 9,553 |
| Net cash provided by financing activities | 18,538 | 276 | 0 | 9,619 |
| Net increase in cash, cash equivalents and restricted cash | 3,940 | 641 | -1,854 | -2,019 |
| Beginning of period | 5,333 | 3,873 | 8,565 | - |
| End of period | 9,273 | 641 | 4,692 | - |
GENELUX Corp (GNLX)
GENELUX Corp (GNLX)